|
Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer |
|
|
|
Titel: |
Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer |
Auteur: |
Fujiwara, Yutaka Tamura, Kenji Kondo, Shunsuke Tanabe, Yuko Iwasa, Satoru Shimomura, Akihiko Kitano, Shigehisa Ogasawara, Ken Turner, P. Kellie Mori, Joji Asou, Hiroya Chan, Edward Michael Yamamoto, Noboru |
Verschenen in: |
Cancer, chemotherapy and pharmacology |
Paginering: |
Jaargang 78 (2016) nr. 2 pagina's 281-288 |
Jaar: |
2016 |
Inhoud: |
|
Uitgever: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|